UA95766C2 - Производные терфенила для лечения болезни альцгеймера - Google Patents

Производные терфенила для лечения болезни альцгеймера

Info

Publication number
UA95766C2
UA95766C2 UAA200813475A UAA200813475A UA95766C2 UA 95766 C2 UA95766 C2 UA 95766C2 UA A200813475 A UAA200813475 A UA A200813475A UA A200813475 A UAA200813475 A UA A200813475A UA 95766 C2 UA95766 C2 UA 95766C2
Authority
UA
Ukraine
Prior art keywords
alzheimer
disease
treatment
terphenyl derivatives
compounds
Prior art date
Application number
UAA200813475A
Other languages
English (en)
Ukrainian (uk)
Inventor
Френсис Вильсон
Элисон Рид
Валери Ридер
Ричард Джон Херрисон
Михиро Сунозе
Ремедиос Эрнадес-Перни
Джереми Мейджор
Сирилл Буссар
Катрин Смелт
Джесс Тейлор
Аделин Леформал
Эндрю Кенсфилд
Свеня Бурккхардт
Чих Юнг Хо
Ян Жанг
Original Assignee
Орто-Макнил-Дженссен Фармасьютикалз, Инк.
Целльзом Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36293499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA95766(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Орто-Макнил-Дженссен Фармасьютикалз, Инк., Целльзом Лтд. filed Critical Орто-Макнил-Дженссен Фармасьютикалз, Инк.
Publication of UA95766C2 publication Critical patent/UA95766C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/33—Polycyclic acids
    • C07C63/331—Polycyclic acids with all carboxyl groups bound to non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/65—Halogen-containing esters of unsaturated acids
UAA200813475A 2006-04-21 2007-04-19 Производные терфенила для лечения болезни альцгеймера UA95766C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06112934A EP1847524B1 (en) 2006-04-21 2006-04-21 Terphenyl derivatives for treatment of Alzheimer's disease

Publications (1)

Publication Number Publication Date
UA95766C2 true UA95766C2 (ru) 2011-08-25

Family

ID=36293499

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200813475A UA95766C2 (ru) 2006-04-21 2007-04-19 Производные терфенила для лечения болезни альцгеймера

Country Status (35)

Country Link
US (1) US8106236B2 (ru)
EP (2) EP1847524B1 (ru)
JP (1) JP5422827B2 (ru)
KR (1) KR101494906B1 (ru)
CN (1) CN101484410B (ru)
AR (1) AR060621A1 (ru)
AT (1) ATE445586T1 (ru)
AU (1) AU2007240382B2 (ru)
BR (1) BRPI0710632A2 (ru)
CA (1) CA2649845C (ru)
CR (2) CR10376A (ru)
CY (1) CY1109729T1 (ru)
DE (1) DE602006009764D1 (ru)
DK (1) DK1847524T3 (ru)
EA (1) EA016908B1 (ru)
ES (2) ES2333539T3 (ru)
GE (1) GEP20115211B (ru)
HK (1) HK1134923A1 (ru)
IL (2) IL194853A0 (ru)
MA (1) MA30420B1 (ru)
MX (1) MX2008013447A (ru)
MY (1) MY148988A (ru)
NO (1) NO20084516L (ru)
NZ (1) NZ572999A (ru)
PE (1) PE20080267A1 (ru)
PL (1) PL1847524T3 (ru)
PT (1) PT1847524E (ru)
SI (1) SI1847524T1 (ru)
SM (1) SMP200800062B (ru)
TN (1) TNSN08414A1 (ru)
TW (1) TWI435720B (ru)
UA (1) UA95766C2 (ru)
UY (1) UY30300A1 (ru)
WO (1) WO2007124351A1 (ru)
ZA (1) ZA200809857B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1847524T3 (da) 2006-04-21 2010-01-11 Cellzome Ltd Terphenylderivater til behandling af Alzheimers sygdom
US8252935B2 (en) 2007-10-19 2012-08-28 Janssen Pharmaceutica N.V. Piperidinyl and piperazinyl modulators of γ-secretase
WO2009052341A1 (en) * 2007-10-19 2009-04-23 Janssen Pharmaceutica, N.V. Gsm intermediates
AU2008312371B2 (en) 2007-10-19 2013-06-20 Janssen Pharmaceutica, N.V. Amine linked modulators of gamma-secretase
WO2009052334A1 (en) 2007-10-19 2009-04-23 Janssen Pharmaceutica, N.V. Carbon linked modulators of y-secretase
WO2009067493A2 (en) * 2007-11-19 2009-05-28 Envivo Pharmaceuticals, Inc. 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
CA2707492A1 (en) * 2007-12-13 2009-06-18 Amgen Inc. Gamma secretase modulators
JP2011507909A (ja) 2007-12-20 2011-03-10 エンビボ ファーマシューティカルズ インコーポレイテッド 四置換ベンゼン
JP2011513460A (ja) * 2008-03-11 2011-04-28 ノイロサーチ アクティーゼルスカブ ニコチン性アセチルコリン受容体のモジュレーターとして有用な新規のトリアリール誘導体
US7968725B2 (en) * 2008-07-22 2011-06-28 Janssen Pharmaceutica N.V. Pyridinyl modulators of γ-secretase
WO2012116452A1 (en) * 2011-03-03 2012-09-07 Denovamed Inc. Antimicrobial/adjuvant compounds and methods
CN103012200B (zh) * 2011-09-20 2014-12-17 北京大学 具有β-分泌酶抑制功能的化合物及其制备方法与应用
WO2015109109A1 (en) 2014-01-15 2015-07-23 Forum Pharmaceuticals Inc. Fused morpholinopyrimidines and methods of use thereof
US9802927B2 (en) 2015-06-10 2017-10-31 Denali Therapeutics, Inc. Oxadiazine compounds and methods of use thereof
WO2022114105A1 (ja) * 2020-11-27 2022-06-02 ミライラボバイオサイエンス株式会社 高純度βニコチンアミドモノヌクレオチド（ＮＭＮ）及びその製造方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08325182A (ja) * 1995-05-31 1996-12-10 Fuji Yakuhin Kogyo Kk 置換テルフェニル誘導体とそれらを含有する抗血栓剤
FR2767525B1 (fr) * 1997-08-21 1999-11-12 Cird Galderma Derives biphenyliques substitues par un radical aromatique ou heteroaromatique et compositions pharmaceutiques et cosmetiques les contenant
EP1178963A1 (en) 1999-05-12 2002-02-13 Neurosearch A/S Ion channel modulating agents
AU5702201A (en) 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
JP2003531194A (ja) * 2000-04-24 2003-10-21 メルク フロスト カナダ アンド カンパニー プロスタグランジンｅ阻害薬としてフェニルおよびビアリール誘導体を用いる治療方法および該方法に有用な化合物
DE60239730D1 (de) * 2001-02-20 2011-05-26 Isis Innovation Metall enthaltende dendrimere
FR2838439B1 (fr) * 2002-04-11 2005-05-20 Sanofi Synthelabo Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
EP1569954A1 (en) * 2002-12-05 2005-09-07 Axys Pharmaceuticals, Inc. Cyanomethyl derivatives as cysteine protease inhibitors
GB0305918D0 (en) 2003-03-14 2003-04-23 Glaxo Group Ltd Novel compounds
CN100441185C (zh) * 2003-04-30 2008-12-10 麦克弗罗斯特加拿大有限公司 8-(3-联芳基)苯基喹啉磷酸二酯酶-4抑制剂
WO2005110963A1 (en) * 2004-05-19 2005-11-24 Cellzome Ag (biphenyl-3-yl)-carboxylic acids and derivatives thereof and their use in therapy
GB0416508D0 (en) 2004-07-23 2004-08-25 Merck Sharp & Dohme Therapeutic agents
CA2618340C (en) * 2005-08-15 2013-11-19 F.Hoffmann-La Roche Ag Piperidine and piperazine derivatives as p2x3 antagonists
JP5155171B2 (ja) 2005-10-06 2013-02-27 アストラゼネカ・アクチエボラーグ 新規化合物
DK1847524T3 (da) 2006-04-21 2010-01-11 Cellzome Ltd Terphenylderivater til behandling af Alzheimers sygdom

Also Published As

Publication number Publication date
EP2016039A1 (en) 2009-01-21
AU2007240382B2 (en) 2013-05-02
JP5422827B2 (ja) 2014-02-19
TWI435720B (zh) 2014-05-01
CA2649845C (en) 2014-09-16
ES2392352T3 (es) 2012-12-10
IL194853A0 (en) 2009-08-03
TW200810746A (en) 2008-03-01
PE20080267A1 (es) 2008-05-16
DE602006009764D1 (de) 2009-11-26
WO2007124351A1 (en) 2007-11-01
US20070254957A1 (en) 2007-11-01
JP2009538275A (ja) 2009-11-05
UY30300A1 (es) 2007-08-31
MX2008013447A (es) 2009-03-10
EP1847524B1 (en) 2009-10-14
AU2007240382A1 (en) 2007-11-01
GEP20115211B (en) 2011-04-26
CY1109729T1 (el) 2014-09-10
BRPI0710632A2 (pt) 2011-08-23
EP1847524A1 (en) 2007-10-24
CR10376A (es) 2009-02-26
IL194789A0 (en) 2009-08-03
SI1847524T1 (sl) 2010-01-29
NO20084516L (no) 2009-01-13
MY148988A (en) 2013-06-28
ZA200809857B (en) 2009-08-26
DK1847524T3 (da) 2010-01-11
MA30420B1 (fr) 2009-05-04
PT1847524E (pt) 2009-12-18
SMAP200800062A (it) 2008-11-19
US8106236B2 (en) 2012-01-31
CN101484410A (zh) 2009-07-15
HK1134923A1 (en) 2010-05-20
EA016908B1 (ru) 2012-08-30
TNSN08414A1 (en) 2010-04-14
EA200802173A1 (ru) 2009-06-30
SMP200800062B (it) 2009-07-14
EP2016039B1 (en) 2012-08-01
CR10452A (es) 2009-02-23
ATE445586T1 (de) 2009-10-15
CN101484410B (zh) 2013-08-21
KR101494906B1 (ko) 2015-02-24
CA2649845A1 (en) 2007-11-01
KR20090024678A (ko) 2009-03-09
NZ572999A (en) 2012-06-29
AR060621A1 (es) 2008-07-02
ES2333539T3 (es) 2010-02-23
PL1847524T3 (pl) 2010-03-31

Similar Documents

Publication Publication Date Title
UA95766C2 (ru) Производные терфенила для лечения болезни альцгеймера
MX2007004763A (es) Acidos carboxilicos (bifenilo) y derivados de los mismos.
EA016129B9 (ru) Замещенные бифенилкарбоновые кислоты и их производные
TW200728307A (en) Novel spirochromanone derivatives
TW200734311A (en) New compounds
HK1119699A1 (en) Pyridopyrimidinone inhibitors of pi3kalpha
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
RS52823B (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
ECSP099755A (es) Derivados de pirrolopiridina y su uso como inhibidores de bace
TW200612958A (en) Substituted imidazole derivatives
MX2008002061A (es) Derivados de tiazolil piperidina utiles como moduladores del receptor h3.
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
TW200736233A (en) Cyclohexyl piperazinyl methanone derivatives
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
MX2010002938A (es) Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer.
TW200738651A (en) Cyclohexyl sulfonamide derivatives
TW200637817A (en) 5-aminoindole derivatives
TW200716547A (en) Piperidin-4-yl-amide derivatives
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
ATE466007T1 (de) 5-substituierte indol-2-carbonsäureamidderivate
UA106200C2 (ru) Замещенные производные оксиндола и их применение для лечения заболеваний, зависимых от вазопресина
TW200700390A (en) Metabolites for nk-1 antagonists for emesis
MX2009005242A (es) Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo.